As the COVID-19 pandemic continues to evolve, NIH has revised its page on Frequently Asked Questions (FAQs) to align with implementation of recent guidance from the Office of Management and Budget (OMB) for recipients affected by COVID-19.
As we continue to navigate the current COVID-19 global pandemic, NIH has resources for Frequently Asked Questions (FAQs) on COVID-19-related funding flexibilities. Recently authorized guidance from the Office of Management and Budget (OMB) extends short-term administrative relief to grant recipients that have been directly impacted by COVID-19 due to loss of operations. NIH has implemented this guidance and revised the FAQs accordingly, with new/updated FAQs indicated as such on the page.
These FAQs address issues that may be relevant to the BRAIN community, including:
- Funding flexibilities and extensions (at the time of submission of application and for current awardees), including an exception to our standard policy on post-submission materials and accepting preliminary data as post-submission materials for applications submitted under all activity codes, with caveats that are subject to change (NOT-OD-20-123).
- Commitment to supporting the workforce, including charging salaries to NIH grants when no work is being performed, which is allowable through September 30, 2020, if your organization’s policy allows for the charging of salaries and benefits to currently active awards (under unexpected or extraordinary circumstances).
- Support for training, including salary support for international students and post-doctoral trainees who can continue to be supported on NIH grant projects, even if they are not able to return to the U.S. because of COVID-19 related travel restrictions.
To view these and all of the updated FAQs, please visit https://grants.nih.gov/faqs#/covid-19.htm.